Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Nash, Peter [1 ]
McInnes, Iain B. [2 ]
Mease, Philip J. [3 ,4 ]
Choy, Ernest H. [5 ,6 ]
Thom, Howard [7 ]
Kalyvas, Chrysostomos [8 ]
Gandhi, Kunal [9 ]
Mpofu, Shephard [10 ]
Jugl, Steffen [10 ]
机构：
[1] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Swedish Med Ctr, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Cardiff Univ, Sch Med, Rheumatol Sect, Cardiff, S Glam, Wales
[6] Cardiff Univ, CREATE Ctr, Div Infect & Immun, Cardiff, S Glam, Wales
[7] Univ Bristol, Bristol, Avon, England
[8] MAPI Grp, Houten, Netherlands
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1738
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SECUKINUMAB SHOWS HIGHER SYMPTOMATIC IMPROVEMENT VERSUS ETANERCEPT IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 24 WEEKS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON
    Mease, P.
    Choy, E.
    Thom, H.
    Kalyvas, C.
    Lopes, N.
    Pricop, L.
    Gandhi, K.
    Jugl, S. M.
    Nash, P.
    VALUE IN HEALTH, 2017, 20 (09) : A936 - A936
  • [22] RELATIVE EFFICACY OF ADALIMUMAB VERSUS SECUKINUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Betts, K. A.
    Mittal, M.
    Song, J.
    Skup, M.
    Joshi, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 98 - 99
  • [23] Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Taieb, Vanessa
    Eells, Jason
    McInnes, Iain B.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1413 - 1423
  • [24] Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Warren, Richard B.
    Mcinnes, Iain B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Willems, Damon
    Taieb, Vanessa
    Eells, Jason
    Mease, Philip J.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (03) : 829 - 839
  • [25] Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Willems, Damon
    Taieb, Vanessa
    Eells, Jason
    Mcinnes, Iain B.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1403 - 1412
  • [26] SECUKINUMAB SHOWS HIGHER SYMPTOMATIC IMPROVEMENT VERSUS INFLIXIMAB IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 1 YEAR ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISONS
    Strand, V
    McInnes, I.
    Thom, H.
    Hunger, M.
    Lopes, N.
    Gandhi, K.
    Jugl, S. M.
    VALUE IN HEALTH, 2017, 20 (09) : A935 - A936
  • [27] Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
    Mahon, Ronan
    Tiwari, Santosh
    Koch, Mirja
    Ferraris, Matias
    Betts, Keith A.
    Wang, Yan
    Gao, Sophie
    Proot, Pascal
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (03)
  • [28] Comparative effectiveness of ozanimod versus dimethyl fumarate: results of a matching-adjusted indirect comparison
    Cohan, S.
    Kumar, J.
    Arndorfer, S.
    Zhu, X.
    Zivkovic, M.
    Tencer, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 140 - 140
  • [29] Comparison of Secukinumab Vs Adalimumab in a Cost per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthritis at 48 Weeks from the US Perspective
    Greenberg, Jeffrey D.
    Nikoglou, Efthalia
    Gunda, Praveen
    Palmer, Jacqueline
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] MATCHING-ADJUSTED INDIRECT COMPARISON OF IXEKIZUMAB VS. TOFACITINIB IN PSORIATIC ARTHRITIS
    Sapin, C.
    Panni, T.
    Meszaros, G.
    Hill, J.
    Hartz, S.
    VALUE IN HEALTH, 2020, 23 : S593 - S593
12345